Halozyme Therapeutics (NasdaqGS:HALO) Q3 2025 Earnings Call November 03, 2025 04:30 PM ET Speaker2Good afternoon. My name is Tiffany, and I will be your conference operator today. At this time, I would like to welcome everyone to Halozyme's third quarter 2025 financial and operating results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during that time, simply ...